Management of Diabetic Ketoacidosis (DKA): Step-by-Step Approach
DKA treatment requires immediate administration of insulin and fluid replacement under specialized medical supervision in a hospital setting, with the goal of reducing glucose levels by 50-100 mg/dL per hour. 1
Diagnosis and Classification
Diagnostic criteria:
- Hyperglycemia (blood glucose >250 mg/dL)
- Acidosis (pH <7.3)
- Bicarbonate <15 mEq/L
- Ketonemia/ketonuria 1
Severity classification:
- Mild: pH 7.2-7.3, bicarbonate 15-18 mEq/L
- Moderate: pH 7.1-7.2, bicarbonate 10-15 mEq/L
- Severe: pH <7.1, bicarbonate <10 mEq/L 1
Initial Assessment and Monitoring
Essential laboratory tests:
- Plasma glucose
- Blood urea nitrogen/creatinine
- Serum ketones
- Electrolytes (especially potassium)
- Serum osmolality
- Arterial blood gases
- Complete blood count
- Urinalysis 1
Monitoring schedule:
- Blood glucose: every 1-2 hours
- Electrolytes, BUN, creatinine: every 2-4 hours
- Venous pH and anion gap: every 2-4 hours
- Continuous cardiac monitoring for T-wave changes 1
Treatment Algorithm
1. Fluid Resuscitation
- Initial phase: Isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour 1
- Subsequent fluid: Choice based on hydration status and electrolytes
- Total deficit replacement: Can be completed orally once patient tolerates oral fluids 2
- Caution: Avoid excessive saline resuscitation to reduce risk of cerebral edema, especially in children 3
2. Insulin Therapy
- Timing: Begin 1-2 hours after starting fluid replacement 1
- Dosing: Continuous IV insulin infusion at 0.1 U/kg/hour 1
- Important: Avoid insulin bolus, especially in children (increases risk of cerebral edema) 1, 3
- Alternative approach: In resource-limited settings without ICU access, subcutaneous rapid-acting insulin analog at 0.15 U/kg every 2-3 hours until resolution of metabolic acidosis 2
3. Electrolyte Replacement
Potassium:
Bicarbonate:
Phosphate:
- Consider replacement in patients with cardiac dysfunction, anemia, respiratory depression, or serum phosphate <1.0 mg/dL 1
4. Identify and Treat Precipitating Factors
- Common precipitants include:
- Infections
- New diagnosis of diabetes
- Insulin non-adherence
- SGLT2 inhibitor use 4
Resolution Criteria and Transition to Subcutaneous Insulin
DKA resolution is indicated by:
- Blood glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
- Normalized anion gap
- Hemodynamic stability 1
Transition to subcutaneous insulin:
- Continue IV insulin for 1-2 hours after first subcutaneous dose
- For Type 1 diabetes: Multiple daily injections or insulin pump therapy
- For Type 2 diabetes: Consider metformin after resolution of ketosis 1
- Alternative approach: Initiate intermediate-acting (NPH) insulin at 0.6-1 U/kg/day approximately 12 hours after treatment initiation 2
Complications and How to Avoid Them
Cerebral edema (most common cause of mortality, especially in children):
- Avoid insulin bolus
- Avoid excessive fluid resuscitation
- Prevent rapid decreases in effective plasma osmolality 3
Hypokalemia:
- Monitor potassium closely
- Ensure adequate potassium replacement before and during insulin therapy 3
Hypoglycemia:
- Add dextrose to IV fluids when glucose falls below 250 mg/dL
- Continue insulin to clear ketones 1
Discharge Planning
Education on:
- Recognition of DKA symptoms
- Sick day management
- Insulin administration
- Blood glucose monitoring 1
Follow-up:
- Schedule appointments with healthcare providers
- Ensure transmission of discharge summaries to primary care providers 1
Insulin regimen:
- Adjust to 0.4-0.7 U/kg/day at discharge 2
- Ensure proper education on administration
By following this structured approach to DKA management, clinicians can effectively treat this potentially life-threatening condition while minimizing complications.